ArticleCannabis and cannabinoid research2023
Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study.
Article in Cannabis and cannabinoid research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 19 citations in OpenAlex.
- Cannabis use and beliefs among people in recovery from substance use disorders.Journal of cannabis research · 2026Article
- Self-reported cannabis use to manage opioid withdrawal symptoms and reductions in opioid use among people who use unregulated opioids: a cross-sectional analysis.Journal of cannabis research · 2026Article
- Redefining Recovery: The Expanding Cannabis Landscape and Its Implications for the California Sober Approach in Addiction.International journal of mental health and addiction · 2026Article
- Non-Medical Use of Prescription Stimulants in Australia: Prevalence, Sociodemographic and Substance Use Correlates From the 2022-2023 National Drug Strategy Household Survey.Drug and alcohol review · 2026Article
- "1, 2, 3, Release": Cannabis Consumption and Mental Health and Well-Being During Pregnancy, Lactation and Parenthood.Cannabis (Albuquerque, N.M.) · 2026Article
- Motivation and experiences of individuals with opioid use disorder and chronic pain using medical cannabis for 12 months.Harm reduction journal · 2025Article
- Conceptualizing 'cannabis harm reduction': lessons learned from cannabis compassion clubs and medical dispensaries in British Columbia (Canada).Harm reduction journal · 2025Article
- Reconceptualizing cannabis use risks in the context of health and social inequities: Insights from a qualitative study with young people in Canada.The International journal on drug policy · 2025Article
- Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain.Drug and alcohol review · 2025Article
- The association of medical cannabis use with quality of life in Illinois' opioid alternative pilot program.Journal of epidemiology and population health · 2025Article
- Cannabis use and alcohol and drug outcomes in a longitudinal sample of sober living house residents in California.Journal of substance use and addiction treatment · 2024Article
- "Smoking weed it gets you over the hump": Cannabis co-use as a facilitator of decreased opioid use among people who inject drugs in Los Angeles, California.Drug and alcohol dependence reports · 2024Article
- "Everything is kind of the same except my mind is with me": exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction.Harm reduction journal · 2024Article
- Patterns of cannabis use, perception of harm, and perceived impact of legislative change in an online sample of young adults from Lebanon: insight on recreational users versus dual motive users.Harm reduction journal · 2024Article
- Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023Review
- Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study.The International journal on drug policy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.